How to spot a strategic inflection point, when a tenfold force changes a business.
Also recommended by: Andrew Chen, Charlie Munger, Jim Collins and 11 others
A teacher's methods for raising independent, successful children.
Also recommended by: Ana Fabrega, Arianna Huffington and 1 other
| Genetic diversity is our greatest strength | Anne Wojcicki on Substack | Newsletter issue | 2026-01-22 |
| 2026, JP Morgan and The 23andMe Research Institute | Anne Wojcicki on Substack | Newsletter issue | 2026-01-20 |
| The Next Chapter of 23andMe | Anne Wojcicki on Substack | Newsletter issue | 2025-07-15 |
| #166 – 23andMe Founder: AI Can’t Crack Biology (Yet) | Anne Wojcicki | Artificial Happiness: Fulfilment in the Age of AI | 2026-10-02 | 48 min | Your DNA holds secrets that could stop disease before it starts. 23andMe co-founder Anne Wojcicki has spent 20 years trying to unlock them. “There’s nothing that humbles an AI researcher like biology.” Anne co-founded 23andMe... |
| Beyond the DNA - Anne Wojcicki | LIFT with Pattie Sellers & Anne Marie Chaker | 2026-09-11 | 53 min | Pattie & Anne Marie sit down with Anne Wojcicki, co-founder of 23andMe, to discuss her journey from Silicon Valley upbringing to revolutionizing personal genetics and her ongoing efforts to advance disease prevention and scientific discovery through her nonprofit. This episode explores her personal story, the evolution of 23andMe, and the future of genetic research. Call the LIFT Line anytime at (888) 947-8277 or write in at LIFTLine@siriusxm.com to ask Pattie & Anne Marie anything! Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising. |
| Breaking the Code: Anne Wojcicki on Genetics, Reinvention, and Rewriting Consumer Health | Breaking Precedent | 2026-09-10 | 55 min | What did Anne Wojcicki see in healthcare that made her leave Wall Street and risk challenging an entire industry to put power back in patients’ hands? Welcome to the brand new season of Breaking Precedent where Leah Solivan interviews 23andMe founder Anne Wojcicki about breaking medical “gatekeeping” by giving consumers direct access to their genetic information and using that data to drive research and prevention. Solivan shares learning she did not carry BRCA2 while pregnant, and Wojcicki recounts motivations shaped by her mother’s fierce self-advocacy, a Stanford community of inquiry, and an immigrant family history that emphasized purpose over materialism. After Yale (biology and a year of hockey) and a Wall Street career that exposed ethical problems in healthcare, Wojcicki drew inspiration from HIV patient advocates to build a platform for people to advocate for themselves. She describes co-founding 23andMe in 2006 with Linda Avey and Paul Cusenza, early public skepticism, the unexpected power of ancestry, medical resistance to broad genetic testing, and how COVID-era telehealth and AI enable new prevention tools. Wojcicki explains buying 23andMe back via a nonprofit to better align incentives, scale research access, and build a subscription product integrating genetics with medical records, self-report data, wearables, and updated insights for personalized risk prediction and guidance. |
| Anne Wojcicki: Why is passion the essential DNA for business breakthroughs? | The Messy Middle | 2026-08-17 | 1:13 | In this episode of The Messy Middle, 23andMe founder Anne Wojcicki shares how her early career in healthcare investing inspired her to build a company that gives people greater access to and control over their health information. She also reflects on the realities of entrepreneurship, the potential of genetics to transform healthcare, and what it takes to stay true to your mission through the ups and downs of building a business. And on this week’s Grab Bag, Blake, Mindy and Mike tackle Wine 101 to help you navigate the wine list with confidence. |
| Stop Disease 5 Years Early: AI + DNA Playbook With 23andMe's Founder Anne Wojcicki | Silicon Valley Girl: AI, Tech and Career Growth | 2026-07-29 | 1:00 | In this episode of the Silicon Valley Girl Podcast, Marina Mogilko sits down with Anne Wojcicki, co-founder and CEO of 23andMe — the genetic testing company that has helped more than 14 million people understand their ancestry and health risks, and built one of the largest human genetic datasets in the world.After 23andMe went through bankruptcy and Anne lost control of the company she started in 2006, she fought to win it back at a court-approved auction and relaunched it as a nonprofit (TTAM Research Institute) — so no single pharma company would ever own your DNA.In this conversation she breaks down what AI + your DNA can actually do for your health right now: predicting disease years before you feel it, the genetic risk factors everyone should test for, why the healthcare system is built to treat disease instead of preventing it, and the small daily habits that move the needle most.She also opens up about the hardest year of her life — losing her sister, former YouTube CEO Susan Wojcicki, to lung cancer, going through bankruptcy, and why she refused to walk away. Plus: raising kids as a founder, having a baby at 45, co-parenting with her ex-husband Sergey Brin, and the single smartest thing you can do for your body in 2026. |
| Anne Wojcicki - 23andMe - Historias de Emprendimiento Guerrilla Emprendimiento de GUERRILLA | Emprendimiento de Guerrilla | 2025-08-26 | 24 min | Anne Wojcicki: La emprendedora que democratizó la genética con 23andMe En un mundo donde la ciencia parecía reservada a laboratorios lejanos y costosos, Anne Wojcicki decidió cambiar las reglas del juego. Cofundadora de 23andMe, ha sido pionera en acercar la genética al gran público, permitiendo que millones de personas descubran sus raíces, sus riesgos de salud y su conexión con la humanidad. S u enfoque audaz, su visión científica y su convicción en el empoderamiento del usuario la han convertido en una de las emprendedoras más influyentes del siglo XXI. ¿Quién es Anne Wojcicki? Anne Wojcicki es una bioemprendedora estadounidense nacida en 1973, conocida mundialmente por cofundar 23andMe, una de las primeras empresas en ofrecer pruebas genéticas directas al consumidor. Su visión de que cada persona pudiera conocer su información genética sin intermediarios revolucionó la biotecnología y provocó debates sobre privacidad, ética y medicina personalizada. |
| Anne Wojcicki Reclaims 23andMe in $305M Deal | Geek News Central Podcast (Video) | 2025-06-16 | 51 min | Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her non-profit TTAM for $305 million, surpassing a prior winning bid from Regeneron. The deal, which excludes the company’s liabilities, may ease public concerns… The post Anne Wojcicki Reclaims 23andMe in $305M Deal #1827 appeared first on Geek News Central. |
| Holiday Travel Rush | Grateful Dead Members Reflect on Phil Lesh's Impact | 23andMe CEO on Vision for Company & Honoring Sister with Focus on Lung Cancer Research | CBS Mornings on the Go | 2024-11-27 | 37 min | The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would allow millions of obese Americans covered by Medicaid and Medicare to be eligible for the drugs. Out-of-pocket costs could plunge as much as 95%. CBS News medical contributor Dr. Celine Gounder explains what to know about the proposed rule. More than 5,000 public schools have closed in recent years, often due to low enrollment, leading to abandoned buildings. One Detroit nonprofit is helping underserved communities repurposed the closed schools. CBS News' Meg Oliver shows how the program is changing neighborhoods and lives. In an exclusive interview with "CBS Mornings" co-host Gayle King, 23andMe CEO Anne Wojcicki discusses the challenges of losing family, recent company changes, and her vision for the company's future. In an exclusive interview, Anne and Janet Wojcicki share how their family is working to raise awareness and fund research following Susan Wojcicki's death from lung cancer. Iconic band The Grateful Dead, is remembering one of the band's original members, Phil Lesh, who died in October at 84 years old. The surviving original members of the band credit Lesh for the impact he made in each of their lives and revealed they were hoping to play together one more time. |
| 23andMe CEO Anne Wojcicki on Elevating Preventive Health through Consumer Genetics | The Minor Consult | 2024-09-18 | 32 min | Dean Lloyd Minor welcomes Anne Wojcicki, CEO and co-founder of 23andMe, for a conversation about how personal genetics can empower consumers to drive healthier futures. They discuss how 23andMe has evolved over nearly two decades, including pioneering direct-to-consumer genetic testing. They also explore challenges and opportunities of partnering with health care providers, the potential for genetic data to elevate preventive health care, and how AI could accelerate innovation in medicine. |
| Extra: Why Is 23andMe Going Under? (Update) | Freakonomics Radio | 2024-04-29 | 1:02 | Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the Wall Street Journal reporter who has been investigating the firm’s collapse. SOURCES:Rolfe Winkler, reporter at The Wall Street Journal.Anne Wojcicki, co-founder and C.E.O. of 23andMe. RESOURCES:"23andMe’s Fall From $6 Billion to Nearly $0," by Rolfe Winkler (The Wall Street Journal, 2024)."23andMe User Data Stolen in Targeted Attack on Ashkenazi Jews," by Lily Hay Newman (Wired, 2023).Inheritance: A Memoir of Genealogy, Paternity, and Love, by Dani Shapiro (2019).How To Raise Successful People: Simple Lessons for Radical Results, by Esther Wojcicki (2019).“Diet and exercise changes following direct-to-consumer personal genomic testing,” by Daiva Elena Nielsen, Deanna Alexis Carere, Catharine Wang, J. Scott Roberts, and Robert C. Green (BMC Medical Genomics, 2016).“The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis,” Gareth J Hollands, David P. French, Simon J. Griffin, A. Toby Prevost, Stephen Sutton, Sarah King, Theresa M. Marteau (The British Medical Journal, 2016). EXTRAS:"Does Your DNA Determine Your Weight?" by No Stupid Questions (2023)."What’s Stopping Us From Curing Rare Diseases?" by Freakonomics, M.D. |
| 23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech | Crucible Moments | 2023-11-16 | 39 min | Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery. Host: Roelof Botha, Sequoia Capital Featuring: Anne Wojcicki, Richard Scheller Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/ |
| Anne Wojcicki: How 23andMe's DNA Testing is Disrupting the Healthcare Industry | Young and Profiting (YAP) with Hala Taha: Entrepreneurship and Self-Improvement Podcast | 2023-09-25 | 1:07 | Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, including findings about predisposition to disease, widely available to consumers. And, in exchange for a swab of spit and a fee, 23andMe provided its customers with unprecedented insight into their own genetic makeup. Now, Wojcicki and her company are at the forefront of a broader movement to expand personalized care and drug options in healthcare. In today’s episode, Anne talks about the challenges in understanding the code of life, the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine and new drug discovery. Anne Wojcicki is a biologist, entrepreneur, and the co-founder and CEO of the personal genomics company 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup. In this episode, Hala and Anne will discuss: - Anne's disillusionment with the U.S. |
| Anne Wojcicki | Exploring Your DNA and Human Genome with 23andMe | The Founder Hour | 2023-05-23 | 1:11 | Anne Wojcicki is an innovative biologist and the co-founder and CEO of personal genomics company 23andMe. In 2006, Anne saw a need for creating a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. The result was 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup. It was named "Invention of the Year" by Time Magazine in 2008, and in 2013, The Fast Company named Anne “The Most Daring CEO.” We spoke with Anne all about her upbringing and the story of how 23andMe came to be. * The Founder Hour is brought to you by Outer. Outer makes the world’s most beautiful, comfortable, innovative, and high-quality outdoor furniture - ALL from sustainable materials - and is the ONLY outdoor furniture with a patented built-in cover to make protecting it effortless. From teak chairs to fire pit tables, everything Outer makes has the look and feel of what you’d expect at a 5-star resort, for less than you’d pay at a big box store for something that won’t last. For a limited time, get 10% off and FREE shipping at www.liveouter.com/thefounderhour . Terms and conditions apply. * This episode is brought to you by “More Than Profit.” If you enjoy The Founder Hour, we think you’ll enjoy this podcast too. It celebrates entrepreneurs, investors, and leaders that are living and working with purpose. |
| Bonus Content: 23andMe's Anne Wojcicki | The Standard | 2022-08-21 | 10 min | Anne Wojcicki, co-founder and CEO of 23andme is a pioneer in the biotech industry, has a well-earned spot on the Forbes ‘Power Women’ list and according to reports, is a billionaire - on paper at least. Anne is nothing if not accomplished. In this episode: How they came up with the idea for 23andme Getting the company off the ground Working and thriving in a male-dominated field Instant feedback & the value of a great work environment Advice for those hoping to become a CEO For all the latest business news head to standard.co.uk/business Hosted on Acast. See acast.com/privacy for more information. |
| David Rubenstein Show: 23andMe CEO Anne Wojcicki | The David Rubenstein Show | 2022-08-11 | 25 min | Anne Wojcicki, 23andMe CEO and co-founder, talks about surprising customers, the importance of genomics and going public with help from Richard Branson. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded July 21 in Palo Alto. See omnystudio.com/listener for privacy information. |
| Title: AppLovin Proposes Merger with Unity, President Biden Signs the CHIPS Act & 23andMe CEO Anne Wojcicki on Results 8/9/22 | TechCheck | 2022-08-09 | 44 min | Our anchors begin today’s show covering app development platform AppLovin’s proposal to acquire video game software company Unity, with insight from CNBC’s David Faber and Plexo Capital Founding Managing Partner Lo Toney. Then, Bank of America analyst Vivek Arya breaks down what President Biden signing the CHIPS Act means for semiconductor makers, and CNBC’s Dom Chu offers a deep dive into some big meme trade movers. Next, 23andMe CEO Anne Wojcicki joins on the heels of the biotech company’s latest results, and Evercore ISI Head of Technical Analysis Rich Ross offers his bull case for software and semis. Later, our Julia Boorstin shares a new profile on Paris Hilton’s push into the metaverse, and CNBC’s Kate Rooney previews crypto exchange Coinbase’s earnings after the bell. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising. |
| Anne Wojcicki, Co-founder and CEO of 23andMe | Money is Not Evil Podcast | 2022-07-26 | 57 min | "By having a large amount of data, we are starting to understand, what does the human genome mean?" In this View From The Top, Alexandra Eitel, MBA '22 sits down with Anne Wojcicki, Co-founder and CEO of 23andMe to discuss breaking down inequality through genetics, statistical power, building trust with transparency , and how digital healthcare is being revolutionized. "I think there should be transparency and there should be choice," says Wojcicki. 👉Become a Paid Subscriber: anchor.fm/ge 👉Get my free book: https://fierce-composer-3082.ck.page/f7262cf1ed 👉SUBSCRIBE/ Leave a Review TO THE PODCAST https://anchor.fm/getu-chandler |
| 23andme’s Anne Wojcicki on revolutionising the biotech industry | How to be a CEO | 2022-07-18 | 20 min | This week we’re joined by Anne Wojcicki, co-founder and CEO of 23andme. A pioneer in the biotech industry, a well-earned spot on the Forbes ‘Power Women’ list and according to reports, a billionaire - on paper at least. Anne is nothing if not accomplished. 23andme was the first to offer autosomal DNA testing for ancestry, which many companies now use globally. Their tests also provide personalised health insights for individuals. Anne co-founded the company in 2006 with Linda Avey and Paul Cusenza. They joined forces with the aim of using genetic information for good and giving people direct access to their medical data. In this episode: How they came up with the idea for 23andme Getting the company off the groundWorking and thriving in a male-dominated fieldHow success seems to be in her bloodInstant feedback & the value of a great work environment The importance of using your platform to support others What the future holds for 23andme & herself For all the latest business news head to standard.co.uk/business Hosted on Acast. See acast.com/privacy for more information. |
| Anne Wojcicki: There’s No Such Thing as the Perfect Dataset | View From The Top | 2022-06-30 | 58 min | Alexandra Eitel, MBA ’22, sits down with Anne Wojcicki, co-founder and CEO of 23andMe to discuss breaking down inequality through genetics and how leaders should build trust by being unabashedly honest. “The guiding principle for 23andMe is transparency and choice. It’s the choice whether you want to get your genetic information, the choice if you want to participate in research, the choice that you don’t want to do all these things. And I think that’s one of the issues I have in healthcare — most times you’re not provided choice and you’re not provided transparency.” Wojcicki also recounts stories from the early days of 23andMe to how she’s navigating hybrid work today. “Everything is about being redefined,” she says. “Work environments are never going to be the same. And so, how do you really have a hybrid environment? And even at different policies, talking to companies about what are you doing for return to office, or are people coming in. How do you manage vaccinations? Everything has been nonstop of helping manage.” Watch this interview on our YouTube channel. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. |
| Minnie Questions with Anne Wojcicki | Spit | 2022-05-05 | 38 min | Minnie Driver questions Anne Wojcicki, founder, and CEO of the personal genomics company 23andMe. Anne shares how her childhood community influenced her business approach, a story of a divided family united by a surprising genetic connection, and the time she went to Siberia in search of peace and quiet. If you like this episode, check out more from the 22 other creators who are also part of this journey. See omnystudio.com/listener for privacy information. |
| Anne Wojcicki | Minnie Questions with Minnie Driver | 2022-04-27 | 35 min | Minnie questions Anne Wojcicki, founder and CEO of the personal genomics company 23andMe. Anne shares how her childhood community influenced her business approach, a story of a divided family united by a surprising genetic connection, and the time she went to Siberia in search of peace and quiet. See omnystudio.com/listener for privacy information. |
| DTC Healthcare with 23andMe CEO Anne Wojcicki | Motley Fool Hidden Gems Investing | 2022-04-24 | 26 min | Genes aren’t always predictive, but understanding them better could dramatically improve our healthcare system. Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe, about her company and why it’s looking to tell you much more than the names of your long-lost relatives. They discuss: - Opportunities in direct-to-consumer healthcare - Creating more personalized medicine - The limits of genetic testing Host: Brian Orelli Guest: Anne Wojcicki Producer: Ricky Mulvey Engineers: Dan Boyd, Brandon Gentry Learn more about your ad choices. Visit megaphone.fm/adchoices |
| 23andMe CEO Anne Wojcicki on Personalizing Healthcare with Genetic Data | A Healthier Future | 2022-03-14 | 35 min | Health is so personal, yet healthcare can feel anything but personalized. Anne Wojcicki, CEO and Co-Founder of 23andMe, is on a mission to change that. In this episode of A Healthier Future, Anne explains what led her on the journey to create a personal genomics company. 23andMe offers home DNA kits to help people understand their ancestry and learn what their genetics say about their health. In Anne’s eyes, people need the right tools to make more informed decisions about their own healthcare, and 23andMe is a key part of that. We hear what epiphanies about the healthcare industry set Anne on a mission to help people take more control over their own health. Anne also explains what it is to be a “daring CEO” and how she tries to be a mentor to others. Anne also discusses how she manages her work-life balance, why it’s important for employees to be happy at home to be productive at work, and how her upbringing shaped her view of the world. Listen to the full episode to hear: Anne’s balanced approach to mixing business and personal lifeHow Anne’s upbringing inspired her Where the idea behind 23andMe came fromWhy Anne felt the healthcare industry focused on the wrong thingsWhat it means to be a patient advocateWhy 23andMe acquired Lemonaid HealthWhat it means to be a daring CEO |
| Anne Wojcicki on Following Your Curiosity | 9 to 5ish with theSkimm | 2022-02-16 | 34 min | Anne Wojcicki always followed her interests. From sneaking into figure skating rinks as a kid, to taking her interest in genetics to the next level and co-founding the genetics company 23andMe, Anne told us how she’s built her career off curiosity. And as 23andMe has faced challenges from regulators and privacy advocates over the years, Anne had to dig into her passion even more to boost morale. In this episode, Anne shares: The 23andMe origin story What boosted morale on her team Why she actively seeks out feedback from naysayers How she’s played the long game with building her company How the tech world has changed for women Learn more about your ad choices. Visit megaphone.fm/adchoices |
| Using Genetic Information to Help People Be Healthy at 100: Anne Wojcicki, CEO of 23andMe | Raise the Line | 2021-09-09 | 25 min | Discovering your ancestry through a DNA saliva test is commonplace and very popular today, but when 23andMe started offering the service to consumers in 2007, it was breaking new ground. “We started 23andMe with this mentality of being an activist brand. I want to empower people with their own genome. Then I want to empower people to essentially come together and be the world's largest community that's driving research forward,” says Anne Wojcicki, Co-founder and CEO of the company. In the past 14 years, she’s largely achieved that founding vision with 11.6 million people using the product and 80% of those consenting to have their information used in research. And, as Wojcicki tells host Shiv Gaglani, a trove of research papers and a constant stream of new genetic information is allowing 23andMe to move into developing therapeutics. The ultimate goal? “I want people to be able to use their genetic information to change their behavior and live to be 100 without any chronically-managed disease,” she says. Don’t miss this revealing discussion from a pioneer in direct-to-consumer healthcare about the impact of digital health, eliminating hierarchy in healthcare and the role providers can play in battling the swamp of medical misinformation. Spoiler: it might involve them learning to dance. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast |
| 372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe | The Foundr Podcast with Nathan Chan | 2021-08-25 | 53 min | You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-made billionaire in the United States. In this episode of the Foundr podcast, learn how the newly minted billionaire built 23andMe from the ground up — plus what the company plans to do next with all that genomic data. Foundr’s Nathan Chan sat down to chat with Wojcicki about: The moment that inspired her to pursue “the solution to life” How she became the first woman to achieve billionaire status via a SPAC merger What it took to provide consumers with never-before-seen access to their genomic data The marketing plan that inspired customers to buy a product they didn’t know they needed How she grew her company from a tiny crew in a roof-less “office” to a team of more than 600 What 23andMe plans to do with the genomic data from 11.6 million people and counting And much more… fdsa Who do you want to see next on the podcast? Comment and let us know! And don't forget to leave us a 5-star review if you loved this episode. Wait, there's more… If you enjoy the Foundr podcast, check out our free trainings . Get exclusive, actionable advice from some of the world's best entrepreneurs. For more Foundr content, follow us on your favorite platform: Foundr.com Instagram YouTube Facebook Twitter LinkedIn Magazine |
| a16z Bio + Health #7: The Power of Patient Data with Anne Wojcicki | a16z Live | 2021-03-30 | 37 min | On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala, Jorge Conde, Julie Yoo, and Vijay Pande, along with a16z cofounder Marc Andreessen, talk to guest Anne Wojcicki, CEO of 23andme. The conversation covers the shifting trends and perceptions at the intersection of bio and tech, the power of patient data and importance of giving people access to their own health data, and advice to founders on when to lead and when to listen. |
| Big Data, Long Lost Relatives, and Drug Development with Anne Wojcicki of 23andMe | The Two Percent | 2020-10-29 | 48 min | Anu and Anne Wojcicki, founder and CEO of 23andMe, discuss disrupting the drug development industry, COVID-19’s long term impact on digital health, bad-ass lesbian pirates, and why with data - there’s no such thing as taking a secret to the grave anymore. |
| Anne Wojcicki | The Power of Genetic Information | CHeT Talks | 2020-09-10 | 52 min | Anne Wojcicki, CEO of 23andMe, talks about using genetic information to prevent diseases. |
| America’s Health Future with 23andMe CEO and Co-Founder Anne Wojcicki | Washington Post Live | 2020-08-14 | 14 min | 23andMe CEO and Co-Founder Anne Wojcicki joined The Post to discuss the research her company is doing into COVID-19 and how companies should handle digital data concerns. |
| Anne Wojcicki on Direct-To-Consumer Healthcare and The Future of Digital Health | Village Global Podcast | 2019-08-11 | 52 min | We are honored to have Anne Wojcicki (@annewoj23), co-founder and CEO of 23andMe, among our small group of luminary LPs whose financial capital and engagement power the next wave of Village Global founders. She joined us in Mountain View for an intimate fireside chat with the first Chief Data Scientist for the United States Office of Science and Technology Policy, DJ Patil (@dpatil). They discussed: - Why the US healthcare system is broken. - The state of direct-to-consumer healthcare. - Tailored medicine and the future of digital health. - 23andMe’s drug discovery efforts and how continuous data monitoring can change how drugs are developed. - The problem with clinical trials and how to fix them. - How Anne would change the US healthcare system if she could wave a magic wand. - The founding of 23andMe and the company’s philosophy. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal. Venture Stories is brought to you by Village Global, is hosted by co-founder and partner, Erik Torenberg and is produced by Brett Bolkowy. |
| 378. 23andMe (and You, and Everyone Else) | Freakonomics Radio | 2019-05-16 | 49 min | The revolution in home DNA testing is giving consumers important, possibly life-changing information. It’s also building a gigantic database that could lead to medical breakthroughs. But how will you deal with upsetting news? What if your privacy is compromised? And are you prepared to have your DNA monetized? We speak with Anne Wojcicki, founder and C.E.O. of 23andMe. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. |
| Science is Coming for Your Secrets at Home & Business | 23andMe founder, Anne Wojcicki | Podcast series / Marketing | Behind the Brand with Bryan Elliott | 2019-03-02 | 15 min | Anne Wojcicki is the the co-founder and chief executive officer of the personal genomics company 23andMe. Was this a timely episode? Yes. As it happens, I'm personally and professionally involved in this topic of DNA tech. And it's not a subject that comes without controversy, critics and skepticism. I get it. It's complicated. While only some of the present positive and negative effects of any ripples (ala Golden State Killer captured by DNA tech) emerge, the jury is still out on what the future holds. My prediction is that it's going to be rough seas before it's smooth sailing. That said, I'm on board. I'm all in because, well, it's personal. I share some of my story here with Anne, I hope you enjoy! Want to get a short note from me each week with what I've learned from interviewing some of the smartest people in the world? It's the best inspiration, eduction, access to events, perks, finds, free stuff and more to help you improve your life and business: https://www.behindthebrand.tv/vip Want to watch the video version of Behind the Brand? http://bit.ly/GetBehindtheBrand Want to read the feature articles I write for my Inc. Magazine byline? https://www.inc.com/author/bryan-elliott Connect with me personally on social media: Instagram: http://instagram.com/1goodbrain Twitter: https://twitter.com/BryanElliott See my film and commercial production work here: http://bit.ly/thegoodbrainwork For business inquiries: producer@thegoodbrain.com Support the show |
| Anne Wojcicki: CEO & Co-Founder, 23andMe | No Limits with Rebecca Jarvis | 2018-04-17 | 32 min | As the CEO and co-Founder of 23andMe, Anne Wojcicki wants people to learn about who they are from the inside out starting with their DNA. She combined her passion for business and science and founded 23andMe in 2006 after starting her career as a healthcare analyst on Wall Street. On this episode, Anne opens up about why she believes her decade on Wall Street was like getting a PhD, the moment she realized that she had to be part of the healthcare industry's solutions, and the importance of perseverance and needing at least a decade before beginning to see your impact. Congratulations to our No Limits Entrepreneur of the Week: Annie Grossman, Co-Founder & Senior Dog Trainer, School For The Dogs Find out more: http://www.schoolforthedogs.com/ Want to be a featured NLEOTW? Know someone who should? Send your nominations to NoLimitswithRJPodcast@Gmail.com Dont forget to subscribe and leave us a review! Its easy! Click here: http://bit.ly/2ks4f90 ABOUT REBECCA JARVIS: Rebecca Jarvis is an Emmy Award-winning journalist and the Chief Biz, Tech and Econ correspondent for ABC News. Instagram.com/RebeccaJarvis Twitter.com/RebeccaJarvis Facebook.com/RebeccaJarvis https://www.linkedin.com/in/rebecca-jarvis-217ba052/ Snapchat: RebeccaJarvis Learn more about your ad choices. Visit megaphone.fm/adchoices |
| Anne Wojcicki : How to Build the Future | Y Combinator Startup Podcast | 2018-04-13 | 29 min | Anne Wojcicki is the cofounder and CEO of 23andMe , which provides direct-to-consumer genetic testing. Sam Altman is the president of YC Group. He interviewed Anne for a series called How To Build The Future, which you can check out on our YouTube channel . |
| Anne Wojcicki: Driving Discovery and Disruption [Entire Talk] | Entrepreneurial Thought Leaders (ETL) | 2017-11-21 | 57 min | Anne Wojcicki, co-founder and CEO of the popular DNA-testing company 23andMe, discusses how providing people with their own genetic data empowers consumers to make better health decisions and advances science. In conversation with Stanford Professor of the Practice Tina Seelig, Wojcicki explains how the intense scrutiny that the DNA-testing company has received is a sign that it is disrupting the status quo. |
| The Promise and Peril of the Genomic Revolution | StarTalk with Neil deGrasse Tyson | 2016-04-29 | 49 min | Get an update from the front lines of the genomic revolution when Neil Tyson interviews Anne Wojcicki, co-founder/CEO of genetic testing company 23andMe. In studio, bioethicist Prof. Robert Klitzman provides perspective. Chuck Nice co-hosts. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early. Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus . Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. |
| Recode Decode: Anne Wojcicki, CEO, 23andMe | Decoder with Nilay Patel | 2016-04-04 | 56 min | Kara Swisher talks with 23andMe CEO Anne Wojcicki about why the personal genomics company's mission is unchanged after a battle with the FDA. Wojcicki argues that understanding one's own genetic traits is part of a broader trend of consumers taking control of their health. She also discusses being a famous female tech executive, what she thinks of 23andMe's embattled peer Elizabeth Holmes of Theranos and why she doesn't read her own press (especially when it is about her relationship with New York Yankees star Alex Rodriguez). Learn more about your ad choices. Visit podcastchoices.com/adchoices |
| Studio 1.0 - Anne Wojcicki (Audio) | Studio 1.0 | 2015-11-11 | 20 min | (Bloomberg) -- Emily Chang sits down with 23andme CEO Anne Wojcicki on "Studio 1.0" See omnystudio.com/listener for privacy information. |
| Episode 14-35 Tech Nation: High Tech Chasms and 23andMe … | TechNation Radio Podcast | 2014-09-02 | 1:00 | On this week’s Tech Nation, Moira speaks with GEOFF MOORE about what happens to a hot tech companies that get a lot of interest early … and then never make it. Then on BioTech Nation, ANNE WOJCICKI , the co-founder and CEO of 23andMe, where there’s plenty new with a grant from the National Institutes of Health and a new partnership with Pfizer. |
| Anne Wojcicki (23andMe) | Fast Company | 2013-11-14 | 27 min | An intimate conversation with Anne Wojcicki and Fast Company's Jill Bernstein. |
BBreaking the Code: Anne Wojcicki on Genetics, Reinvention, and Rewriting Consumer HealthBreaking Precedent · 2026-09-10
TAnne Wojcicki: Why is passion the essential DNA for business breakthroughs?The Messy Middle · 2026-08-17
SStop Disease 5 Years Early: AI + DNA Playbook With 23andMe's Founder Anne WojcickiSilicon Valley Girl: AI, Tech and Career Growth · 2026-07-29
EAnne Wojcicki - 23andMe - Historias de Emprendimiento Guerrilla Emprendimiento de GUERRILLAEmprendimiento de Guerrilla · 2025-08-26
CHoliday Travel Rush | Grateful Dead Members Reflect on Phil Lesh's Impact | 23andMe CEO on Vision for Company & Honoring Sister with Focus on Lung Cancer ResearchCBS Mornings on the Go · 2024-11-27
T23andMe CEO Anne Wojcicki on Elevating Preventive Health through Consumer GeneticsThe Minor Consult · 2024-09-18
C23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health techCrucible Moments · 2023-11-16
YAnne Wojcicki: How 23andMe's DNA Testing is Disrupting the Healthcare IndustryYoung and Profiting (YAP) with Hala Taha: Entrepreneurship and Self-Improvement Podcast · 2023-09-25
TAnne Wojcicki | Exploring Your DNA and Human Genome with 23andMeThe Founder Hour · 2023-05-23
TBonus Content: 23andMe's Anne WojcickiThe Standard · 2022-08-21
TDavid Rubenstein Show: 23andMe CEO Anne WojcickiThe David Rubenstein Show · 2022-08-11
MAnne Wojcicki, Co-founder and CEO of 23andMeMoney is Not Evil Podcast · 2022-07-26
H23andme’s Anne Wojcicki on revolutionising the biotech industryHow to be a CEO · 2022-07-18
VAnne Wojcicki: There’s No Such Thing as the Perfect DatasetView From The Top · 2022-06-30
A23andMe CEO Anne Wojcicki on Personalizing Healthcare with Genetic DataA Healthier Future · 2022-03-14
RUsing Genetic Information to Help People Be Healthy at 100: Anne Wojcicki, CEO of 23andMeRaise the Line · 2021-09-09
T372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMeThe Foundr Podcast with Nathan Chan · 2021-08-25
aa16z Bio + Health #7: The Power of Patient Data with Anne Wojcickia16z Live · 2021-03-30
CAnne Wojcicki | The Power of Genetic InformationCHeT Talks · 2020-09-10
WAmerica’s Health Future with 23andMe CEO and Co-Founder Anne WojcickiWashington Post Live · 2020-08-14
VAnne Wojcicki on Direct-To-Consumer Healthcare and The Future of Digital HealthVillage Global Podcast · 2019-08-11
F378. 23andMe (and You, and Everyone Else)Freakonomics Radio · 2019-05-16
YAnne Wojcicki : How to Build the FutureY Combinator Startup Podcast · 2018-04-13
EAnne Wojcicki: Driving Discovery and Disruption [Entire Talk]Entrepreneurial Thought Leaders (ETL) · 2017-11-21
SThe Promise and Peril of the Genomic RevolutionStarTalk with Neil deGrasse Tyson · 2016-04-29
DRecode Decode: Anne Wojcicki, CEO, 23andMeDecoder with Nilay Patel · 2016-04-04
TEpisode 14-35 Tech Nation: High Tech Chasms and 23andMe …TechNation Radio Podcast · 2014-09-02